Agilent Technologies Inc
NYSE:A
EV/GP
Enterprise Value to Gross Profit
Market Cap | EV/GP | ||||
---|---|---|---|---|---|
US |
Agilent Technologies Inc
NYSE:A
|
42.6B USD | 12.8 | ||
US |
Thermo Fisher Scientific Inc
NYSE:TMO
|
224.7B USD | 14.5 | ||
US |
Danaher Corp
NYSE:DHR
|
184.6B USD | 13.9 | ||
JP |
CMIC Holdings Co Ltd
TSE:2309
|
16.9T JPY | 811.7 | ||
US |
IQVIA Holdings Inc
NYSE:IQV
|
45.9B USD | 10.9 | ||
KR |
Samsung Biologics Co Ltd
KRX:207940
|
59.3T KRW | 32.4 | ||
CH |
Lonza Group AG
SIX:LONN
|
39B CHF | 16.6 | ||
US |
West Pharmaceutical Services Inc
NYSE:WST
|
29.1B USD | 25.1 | ||
US |
Mettler-Toledo International Inc
NYSE:MTD
|
28.7B USD | 13.6 | ||
IE |
ICON PLC
NASDAQ:ICLR
|
27.7B USD | 12.9 | ||
FR |
Sartorius Stedim Biotech SA
PAR:DIM
|
24.4B EUR | 22.6 |
EV/GP Forward Multiples
Forward EV/GP multiple is a version of the EV/GP ratio that uses forecasted gross profit for the EV/GP calculation. 1-Year, 2-Years, and 3-Years forwards use gross profit forecasts for 1, 2, and 3 years ahead, respectively.